Abstract
Asparaginase plays an integral role in chemotherapy for acute lymphoblastic leukemia (ALL). We present a 69-year old woman with refractory ALL, who developed asparaginase-induced hepatotoxicity and cholangiopathy after starting intravenous PEG-L-asparaginase-based chemotherapy. The patient was ultimately treated with the combination of L-carnitine and vitamin B complex, resulting in normalization of liver enzymes levels. This case highlights the consideration of PEG-L asparaginase chemotherapy-induced liver steatosis, injury, and cholangiopathy as well as the role of L-carnitine and vitamin B complex as treatment.
| Original language | English (US) |
|---|---|
| Pages (from-to) | e16917 |
| Journal | Cureus |
| Volume | 13 |
| Issue number | 8 |
| DOIs | |
| State | Published - Aug 2021 |
Bibliographical note
Copyright © 2021, Lee et al.PubMed: MeSH publication types
- Case Reports